VSBC (VitaSpring Biomedical Co) Debt-to-Equity : 0.20 (As of Oct. 2022)

VitaSpring Biomedical Co Debt-to-Equity Chart

VitaSpring Biomedical Co Quarterly Data
	Jan18	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22
Debt-to-Equity	Get a 7-Day Free Trial															0.94	0.29	0.22	0.21	0.20

Competitive Comparison of VitaSpring Biomedical Co's Debt-to-Equity

For the Biotechnology subindustry, VitaSpring Biomedical Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

VitaSpring Biomedical Co's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, VitaSpring Biomedical Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where VitaSpring Biomedical Co's Debt-to-Equity falls into.

VitaSpring Biomedical Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

VitaSpring Biomedical Co's Debt to Equity Ratio for the fiscal year that ended in Jan. 2022 is calculated as

VitaSpring Biomedical Co's Debt to Equity Ratio for the quarter that ended in Oct. 2022 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

VitaSpring Biomedical Co  (OTCPK:VSBC) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

VitaSpring Biomedical Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of VitaSpring Biomedical Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

VitaSpring Biomedical Co Business Description